Posted by Michael Wonder on 24 Nov 2015
Expensive new Hep C drugs may be cost-effective even for early disease
23 November 2015 - Treating hepatitis C with expensive new medicines at the earliest signs of liver damage improves patients' health and is also cost-effective, a new computer simulation suggests.
For more details, go to: http://www.reuters.com/article/2015/11/23/us-health-hepc-drug-costs-idUSKBN0TC2ES20151123#ZzlCu5ci5jLpTjIH.97
